MedPath
NMPA Approval

Nalfurafine Hydrochloride Orally Disintegrating Tablets

国药准字HJ20230091

September 13, 2023

Drug Information

盐酸纳呋拉啡口崩片

丽美治

片剂

2.5μg

化学药品

September 13, 2023

June 29, 2028

Company Information

Applicant Company

1-1,Nihonbashi Muromachi 2-chome,Chuo-ku,Tokyo 103-8666, JAPAN

Manufacturing Company

bushu pharmaceuticals ltd. kawagoe factory

1 Takeno, Kawagoe, Saitama,350-0801, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸纳呋拉啡口崩片 - NMPA 批准文号 | MedPath